Skip to main content
M3, Inc. logo

M3, Inc. — Investor Relations & Filings

Ticker · 2413 ISIN · JP3435750009 LEI · 3538001UOKRWIODYM055 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 97 across all filing types
Latest filing 2024-06-27 Governance Information
Country JP Japan
Listing T 2413

About M3, Inc.

https://corporate.m3.com/en

M3, Inc. operates a global online platform for medical professionals, connecting a community of over 6.5 million physicians worldwide. The company provides a range of technology-driven services aimed at advancing healthcare innovation and reform. Core offerings include healthcare market research, medical staffing and career development, telemedicine platforms, and support for clinical trials. By leveraging its digital platform, M3 seeks to provide valuable information and services to healthcare professionals, with the ultimate goal of helping people live longer, healthier lives while reducing unnecessary medical costs.

Recent filings

Filing Released Lang Actions
内部統制報告書－第24期(2023/04/01－2024/03/31)
Governance Information Classification · 1% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the cover section and throughout the text. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report in Japan. The content details the framework, scope, criteria (using the end of the fiscal year, March 31, 2024, as the 'as of' date), and the conclusion that internal controls over financial reporting are effective. This directly corresponds to the requirements for an Internal Control Report, which is a mandatory disclosure in Japan, often filed alongside the Annual Report (10-K equivalent) or as a standalone document. Given the specific nature of this report focusing solely on internal controls over financial reporting, it aligns best with the general 'Audit Report / Information' category (AR) as it relates to assurance and control testing, although it is a specific Japanese regulatory filing. However, since there is no specific code for the Japanese 'Internal Control Report' (J-SOX report), and it is a comprehensive report on internal controls, it is distinct from a standard Audit Report (AR) which usually focuses on the auditor's opinion. Given the options, and recognizing this is a formal, comprehensive report on internal controls, it is closest in function to an Audit Report/Information (AR) or potentially a Governance Information (CGR) document, but the explicit focus on 'Internal Control Report' makes it a specialized assurance document. Since 'AR' covers 'applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)', and this is a report on the effectiveness of internal controls over financial reporting, AR is the most appropriate fit among the provided codes for a formal assurance/control document that is not the full 10-K.
2024-06-27 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references the Financial Instruments and Exchange Act (金融商品取引法). It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2024
2024-06-27 Japanese
有価証券報告書－第24期(2023/04/01－2024/03/31)
Annual Report
2024-06-27 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is titled "訂正臨時報告書" (Correction Extraordinary Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 2-2 of the Cabinet Office Ordinance on Disclosure of Corporate Information. The content details the resolution by the Board of Directors to issue stock options (新株予約権) to employees of a wholly-owned subsidiary. This structure and legal basis strongly indicate a filing related to a significant, non-periodic corporate event requiring immediate disclosure, which aligns with the definition of an Extraordinary Report or similar regulatory filing. Since the core subject is the issuance of stock options (a form of capital/financing activity, but filed as a specific regulatory disclosure), and it is explicitly labeled as a '臨時報告書' (Extraordinary Report), the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general catch-all for specific Japanese regulatory disclosures that don't perfectly match the other categories, or potentially 'Capital/Financing Update' (CAP). However, given the explicit reference to the '臨時報告書' filing requirement under Japanese law, RNS is the safest classification for specific, non-standard regulatory disclosures not covered by 10-K, IR, or ER. The document length (4971 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA). Since 'Extraordinary Report' is not a direct code, and this is a mandatory regulatory disclosure, RNS is the best fit.
2024-04-16 Japanese
臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director ("関東財務局長"). The filing reason explicitly states that the company resolved to issue stock options (新株予約権の発行) to employees of a wholly-owned subsidiary, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 2-2 of the Cabinet Office Ordinance on Disclosure of Corporate Information. This structure and content—a formal, mandatory disclosure regarding a specific corporate action (issuance of stock options to employees) filed outside of regular reporting cycles—aligns best with a general regulatory filing or timely disclosure. Since there is no specific category for 'Stock Option Grant Report,' and it is a mandatory regulatory filing that doesn't fit 10-K, ER, or IR, the most appropriate fallback is Regulatory Filings (RNS). The document length (4960 chars) is not short enough to definitively classify it as just an announcement (RPA) without seeing the full context, but its nature as a formal disclosure document makes RNS a strong fit.
2024-03-29 Japanese
臨時報告書
Regulatory Filings Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director (関東財務局長). The filing reason explicitly states that an event significantly impacting the company's financial condition has occurred, citing Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related regulations. The content details the receipt of dividends from subsidiaries, which impacts the non-operating income in the non-consolidated financial statements for the fiscal year ending March 2024. This structure—a formal, timely disclosure of a significant, non-periodic financial event (like a large dividend receipt) filed under Japanese regulations (EDINET system)—does not fit neatly into the standard periodic reports (10-K, IR) or specific announcements (ER, DIV). It is a general regulatory disclosure that doesn't match the specific definitions provided (like AGM-R, CT, DIRS, etc.). Therefore, the most appropriate classification is the general regulatory filing fallback category.
2024-03-22 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.